ISPOR Working Group provides a first-ever cross-stakeholder consensus definition of “Patient Engagement in Research”

 7 July 2020 - Value in Health announced today the publication of results of an ISPOR systematic review and analysis ...

Read more →

Patients’ and health care professionals’ organisations updated on EMA’s response to COVID-19

 4 June 2020 - EMA updated patients’ and healthcare professionals’ organisations about its COVID-19 activities.  ...

Read more →

Consumer comments needed for proposed new listings on the PBS

12 May 2020 - Lung Foundation Australia is seeking input from consumers to inform submissions on proposed listings of respiratory ...

Read more →

Evaluation of the impact of patient involvement in health technology assessments: a scoping review

8 May 2020 - While involving patients in health technology assessment has become increasingly common and important around the world, little ...

Read more →

Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies

7 May 2020 - Health technology assessment recommendations informed by patient concerns are seen to ensure democracy and legitimacy.  ...

Read more →

ICER Appoints Yvette Venable as Vice President of Patient Engagement

16 April 2020 - The Institute for Clinical and Economic Review has announced the appointment of Yvette Venable as the organisation’s ...

Read more →

Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes

10 March 2020 - The terminology used to describe community participation in health technology assessment is contested and frequently confusing.  ...

Read more →

TLV has decided on a policy for patient participation

21 February 2020 - TLV has taken another step in developing patient participation by developing a policy.  ...

Read more →

The FDA wants to know how Instagram influencers sway patient views on medicines

28 January 2020 - In 2015, Kim Kardashian promoted a morning-sickness pill to her millions of followers on social media, ...

Read more →

Use of patient preference studies in HTA decision making: a NICE perspective

16 January 2020 - Patient preference studies could provide valuable insights to a National Institute for Health and Care Excellence committee ...

Read more →

Engaging patients in medicines regulation: a tale of two agencies

2 December 2019 - The EMA and the US FDA have committed to engaging patients in their regulatory processes to promote ...

Read more →

Patient perspective is vital to FDA's work

7 November 2019 - As an oncologist, I was eager to come work at the U.S. FDA, where I knew ...

Read more →

Advancing patient engagement

2 October 2019 - It’s widely accepted that seeking patient input into their health and care improves outcomes for them and ...

Read more →

Statement on FDA efforts to encourage patient engagement in medical device clinical investigations

23 September 2019 - At the U.S. FDA we are committed to keeping patients, their families and caregivers at the center ...

Read more →

A watchdog group sets aside emotions to assess drugs’ value. Patients say their lives are more than a number.

2 August 2019 - Health economists walk a precarious tightrope: their analyses are quantitative and, presumably, emotion-free. But health care ...

Read more →